secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001493152-23-015864
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim reports Q1 2023 revenue up 95% YoY to $25.8M, achieves positive GAAP net income of $227K
--------------------------------------------------------------------------------

- Net revenues $25.8M, up 95% YoY from $13.3M; up 7% sequentially from $24.1M.
- Positive GAAP net income of $227K vs net loss of $7.2M in Q1 2022.
- Gross profit margin improved to 16% vs 12% in prior-year quarter.
- Regained compliance with Nasdaq minimum bid price rule; SEC investigation concluded without enforcement.
- Cash and equivalents $9.0M, essentially debt-free.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315223015864/0001493152-23-015864-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315223015864/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-015864

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer